Shop

Home Product Aducanumab

Aducanumab

Aducanumab is under study as a possible treatment for early Alzheimer’s disease.

Aducanumab (Pending FDA Approval)

Classes: Monoclonal Antibodies, Anti-amyloid Beta

What is Aducanumab?

Aducanumab is under study as a possible treatment of early Alzheimer’s disease and currently pending FDA approval.

Uses of Aducanumab

  • possible treatment of early Alzheimer’s disease.

Side effects

Consult your doctor immediately if any side effects occur, worsen, persist or any serious side effects occur.

Precautions

Consult your Physician.

Reviews

There are no reviews yet.

Be the first to review “Aducanumab”

Your email address will not be published. Required fields are marked *